摘要
目的观察后部玻璃体切除联合超声乳化及人工晶状体植入术(简称“后三联手术”)治疗糖尿病性视网膜病变的疗效。方法对44眼行后三联手术的糖尿病性视网膜病变进行回顾性分析,并与行单纯玻璃体切除术的50眼糖尿病性视网膜病变进行对比。结果术后随访2～20月,后三联手术组术后视力0.06以上者43眼(97.73%),0.3以上10眼(22.73%),0.5以上10眼(22.73%);单纯玻璃体切除组术后视力0.06以上者44眼(88.00%),0.3以上8眼(16.00%),0.5以上6眼(12.00%),随访期间22眼(44.00%)二次行白内障手术。结论后部玻璃体切除联合超声乳化人工晶状体植入术治疗增生期糖尿病性视网膜病变是可行的。
Objective To observe the effect of posterior vitrectomy combined with phacoemulsification and IOL implantation for proliferative diabetic retinopathy. Methods A retrospective study was made on 44 eyes of PDR performing posterior tripple procedure, which was compared with 50 eyes of simple posterior vitrectomy without phacoemulsification. Results Following 2 - 20 months postoperatively, in combination group 97.7% （43 eyes） VA was more than 0.06, while both 22.73%（10 eyes） VA was more than 0.3 and 0.5 respectively. In simple group 88.0% VA（44 eyes） was more than 0.06,while 16% （8 eyes） and 12% （6 eyes）VA was more than 0.1 and 0.4 respectively. 44% eyes were performed the second surgery of phacoemulsifieation. Conclusions Posterior vitrectomy combined with phacoemulsification and IOL implantation was a safe and effective method for proliferative diabetic retinopathy.
出处
《眼外伤职业眼病杂志》
北大核心
2006年第12期915-917,共3页
Journal of Injuries and Occupational Diseases of the Eye with Ophthalmic Surgeries
